Skip to main content
. Author manuscript; available in PMC: 2014 Aug 15.
Published in final edited form as: Breast Cancer Res Treat. 2013 Aug 14;141(1):155–163. doi: 10.1007/s10549-013-2656-1

Table 2. Factors associated with receipt of preoperative breast MRI.

MRI No MRI Crude Adjusted OR
(95% CI)
Adjusted P-value
N % N % P-value
Total 7,333 10.1% 65,128 89.9%
Age group
 67-69 1,864 15.8% 9,926 84.2% <.001 Reference <.001
 70-74 2,506 12.8% 17,057 87.2% 0.82 (0.76-0.88)
 75-79 1,706 9.1% 16,989 90.9% 0.59 (0.55-0.64)
 80-84 898 6.6% 12,661 93.4% 0.40 (0.36-0.44)
 85+ 359 4.1% 8,495 95.9% 0.25 (0.22-0.29)
Race
 White 6,764 10.4% 58,426 89.6% <.001 Reference .001
 Black 279 6.1% 4,317 93.9% 0.79 (0.69-0.91)
 Other 290 10.8% 2,385 89.2% 0.87 (0.75-1.00)
Marital Status
 Married 3,877 12.5% 27,106 87.5% <.001 Reference <.001
 Unmarried 3,148 8.1% 35,540 91.9% 0.85 (0.80-0.90)
 Other 308 11.0% 2,482 89.0% 1.14 (0.99-1.31)
Median income of zip code
 Less than $33,000 826 5.6% 14,024 94.4% <.001 Reference <.001
 $33,000-40,000 779 7.1% 10,146 92.9% 1.21 (1.08-1.35)
 $40,000-50,000 1,387 9.2% 13,703 90.8% 1.48 (1.34-1.63)
 $50,000-63,000 1,587 11.3% 12,515 88.7% 1.79 (1.62-1.98)
 More than $63,000* >2,743 >15.7% <14,721 <84.3% 2.68 (2.43-2.96)
 Unknown* <11 <36.7% >19 >63.3% 2.88(0.74-11.23)
Comorbidity
 None 3,900 11.7% 29,562 88.3% <.001 Reference <.001
 1 to 2 2,739 9.8% 25,112 90.2% 0.84 (0.79-0.89)
 3 or more 694 6.2% 10,454 93.8% 0.54 (0.49-0.59)
Stage
 I 4,160 10.2% 36,471 89.8% .17 Reference <.001
 II 2,503 9.8% 22,924 90.2% 1.25 (1.11-1.40)
 III 670 10.5% 5,733 89.5% 1.00 (0.81-1.24)
Tumor size
 <2.0 cm 4,729 10.7% 39,347 89.3% <.001 Reference <.001
 2.0-<=5.0 cm 2,186 9.1% 21,947 90.9% 0.87 (0.79-0.95)
 >5.0 cm 353 9.6% 3,316 90.4% 1.12 (0.95-1.32)
 Missing 65 11.1% 518 88.9% 1.41 (1.03-1.91)
Grade
 Well differentiated 1,894 11.0% 15,361 89.0% <.001 Reference <.001
 Moderately differentiated 3,403 10.9% 27,692 89.1% 1.03 (0.96-1.10)
 Poorly differentiated 1,625 8.8% 16,936 91.2% 0.82 (0.76-0.90)
 Undifferentiated 38 5.3% 678 94.7% 0.78 (0.54-1.11)
 Unknown 373 7.7% 4,461 92.3% 1.13 (0.99-1.28)
Number positive lymph nodes
 No positive nodes 5,096 11.2% 40,583 88.8% <.001 Reference <.001
 1-3 positive nodes 1,355 10.9% 11,021 89.1% 1.01 (0.92-1.12)
 4+ positive modes 549 9.6% 5,164 90.4% 1.18 (0.98-1.42)
 No nodes Examined 304 3.6% 8,070 96.4% 0.52 (0.45-0.59)
 Unknown # Positive Nodes 29 9.1% 290 90.9% 1.15 (0.74-1.77)
Hormone receptors
 ER+ or PR+ 6,121 10.9% 49,993 89.1% <.001 Reference .002
 ER– and PR– 900 9.9% 8,163 90.1% 1.02 (0.93-1.11)
 Missing 312 4.3% 6,972 95.7% 0.80 (0.70-0.91)
Bilateral Breast Cancer
 Yes (bilateral) 443 22.7% 1,508 77.3% <.001 Not Included
 No (unilateral) 6,890 9.8% 63,620 90.2%
*

Values expressed as a range to conform to SEER-Medicare policy of not publishing cell sizes <11. Odds ratios adjusted for all variables in table as well as year of diagnosis and SEER region.